Novartis reported $118.46B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alcon AG ALC:SW USD 27.8B 69M
Amgen AMGN:US USD 63.7B 4.41B
Artemis Alpha ATS:LN GBP 129.48M 35.04M
AstraZeneca AZN:LN USD 94.18B 2.39B
Bayer BAYN:GR EUR 131.01B 2.22B
Biogen BIIB:US USD 24.85B 227.2M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Eli Lilly And LLY:US USD 47.46B 397.9M
Fresenius FRE:GR EUR 80.33B 4.22B
Fresenius Medical Care FME:GR EUR 38.41B 2.34B
Galapagos GLPG:NA EUR 4.97B 68.02M
Genmab GEN:DC DKK 30.69B 3.21B
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Hikma Pharmaceutical HIK:LN USD 4.75B 375M
Lonza Group LONN:SW CHF 16.74B 284M
Merck MRK:GR EUR 50.93B 2.22B
Novartis NVS:US USD 118.46B 4.45B
Novartis NOVN:VX USD 118.46B 4.45B
Orion ORNBV:FH EUR 1.57B 296.7M
Recordati REC:IM EUR 3.98B 6.24M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Roche Holding ROG:VX 86.74B 5.58B